Description

Enterosgel (hydrogel of methyl silicic acid) paste sachet 15 g. №15

Ingredients

Active ingredient: Hydrogel of methyl silicic acid.
Other ingredients: Purified water.

Dosage

Adults and children over 12 years: Take 1-1.5 tablespoons 3 times a day.
Children 5-12 years: Take 1-1.5 teaspoons 3 times a day.
Mix with water or other liquid and drink.

Indications

Enterosgel paste is indicated for the symptomatic treatment of acute diarrhea in adults and children. It works by binding toxins and pathogens in the gastrointestinal tract, reducing their absorption and promoting their elimination.

Contraindications

Do not use Enterosgel paste if you are allergic to any of the ingredients. Consult a healthcare professional before use if pregnant, breastfeeding, or taking other medications.

Directions

Empty the contents of one sachet into a glass, add water, mix well, and drink immediately.
Do not exceed the recommended dosage.
Consult a healthcare provider if symptoms persist.

Scientific Evidence

Enterosgel has been studied for its efficacy in managing acute diarrhea. Research published in the journal “Therapeutic Advances in Gastroenterology” demonstrated that hydrogel of methyl silicic acid can effectively reduce the duration and severity of diarrhea episodes by binding toxins in the gut.

Additional Information

Enterosgel is a well-tolerated treatment option for acute diarrhea with minimal side effects. It is non-absorbable and excreted from the body without systemic effects.
Clinical trials have shown that Enterosgel can help restore normal bowel function and improve overall well-being in patients with acute diarrhea.

Pharmacological Effects: Enterosgel acts as a selective enterosorbent, adsorbing toxins, pathogens, and allergens in the gastrointestinal tract. It forms a protective gel-like layer along the intestinal wall, preventing harmful substances from being absorbed into the bloodstream.

Clinical Trials: A randomized controlled trial published in the “European Journal of Gastroenterology & Hepatology” showed that patients treated with Enterosgel experienced a significant reduction in the frequency and severity of diarrhea compared to placebo, highlighting its clinical efficacy and safety profile.